UA78211C2 - Salts of fructopyranose derivatives as anticonvulsant - Google Patents

Salts of fructopyranose derivatives as anticonvulsant Download PDF

Info

Publication number
UA78211C2
UA78211C2 UA2004010229A UA2004010229A UA78211C2 UA 78211 C2 UA78211 C2 UA 78211C2 UA 2004010229 A UA2004010229 A UA 2004010229A UA 2004010229 A UA2004010229 A UA 2004010229A UA 78211 C2 UA78211 C2 UA 78211C2
Authority
UA
Ukraine
Prior art keywords
formula
compound
salt
sodium
potassium
Prior art date
Application number
UA2004010229A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23174444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA78211(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of UA78211C2 publication Critical patent/UA78211C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
UA2004010229A 2001-07-09 2002-03-07 Salts of fructopyranose derivatives as anticonvulsant UA78211C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30396201P 2001-07-09 2001-07-09
PCT/US2002/021016 WO2003006467A1 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts

Publications (1)

Publication Number Publication Date
UA78211C2 true UA78211C2 (en) 2007-03-15

Family

ID=23174444

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2004010229A UA78211C2 (en) 2001-07-09 2002-03-07 Salts of fructopyranose derivatives as anticonvulsant

Country Status (27)

Country Link
US (2) US7098188B2 (da)
EP (1) EP1414824B1 (da)
JP (1) JP2005502629A (da)
KR (1) KR20040013127A (da)
CN (1) CN1288159C (da)
AR (1) AR036137A1 (da)
AT (1) ATE361304T1 (da)
AU (1) AU2002346042B2 (da)
BR (1) BR0211063A (da)
CA (1) CA2452612A1 (da)
DE (1) DE60219922T2 (da)
DK (1) DK1414824T3 (da)
ES (1) ES2284884T3 (da)
HK (1) HK1064094A1 (da)
HR (1) HRP20040017A2 (da)
HU (1) HUP0401080A2 (da)
IL (2) IL159698A0 (da)
MX (1) MXPA04000232A (da)
NO (1) NO20040066L (da)
NZ (1) NZ530507A (da)
PL (1) PL367635A1 (da)
PT (1) PT1414824E (da)
RU (1) RU2320665C2 (da)
SI (1) SI21370A (da)
UA (1) UA78211C2 (da)
WO (1) WO2003006467A1 (da)
ZA (1) ZA200400970B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US7041650B2 (en) 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US20030092636A1 (en) * 2001-11-06 2003-05-15 Silberstein Stephen D. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2006500377A (ja) * 2002-06-21 2006-01-05 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 改善された溶解性を有する医薬組成物
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9489372B2 (en) * 2013-03-15 2016-11-08 Apple Inc. Web-based spell checker
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
DK1158973T3 (da) 1999-02-24 2005-05-30 Univ Cincinnati Anvendelse af sulfamatderivater til behandling af impulskontrolafvigelser
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
US20060105966A1 (en) 2006-05-18
DE60219922D1 (de) 2007-06-14
US7098188B2 (en) 2006-08-29
AR036137A1 (es) 2004-08-11
RU2320665C2 (ru) 2008-03-27
AU2002346042B8 (en) 2003-01-29
DE60219922T2 (de) 2008-01-17
HK1064094A1 (en) 2005-01-21
AU2002346042B2 (en) 2007-10-18
RU2004100274A (ru) 2005-06-20
NZ530507A (en) 2007-01-26
HRP20040017A2 (en) 2004-10-31
ES2284884T3 (es) 2007-11-16
EP1414824B1 (en) 2007-05-02
IL159698A0 (en) 2004-06-20
WO2003006467A1 (en) 2003-01-23
EP1414824A1 (en) 2004-05-06
HUP0401080A2 (hu) 2004-09-28
SI21370A (sl) 2004-06-30
JP2005502629A (ja) 2005-01-27
DK1414824T3 (da) 2007-07-16
PT1414824E (pt) 2007-06-27
PL367635A1 (en) 2005-03-07
CN1551882A (zh) 2004-12-01
ATE361304T1 (de) 2007-05-15
CN1288159C (zh) 2006-12-06
US20030069190A1 (en) 2003-04-10
NO20040066L (no) 2004-03-01
BR0211063A (pt) 2004-07-20
ZA200400970B (en) 2005-02-07
CA2452612A1 (en) 2003-01-23
KR20040013127A (ko) 2004-02-11
IL159698A (en) 2009-09-22
MXPA04000232A (es) 2005-03-07

Similar Documents

Publication Publication Date Title
UA78211C2 (en) Salts of fructopyranose derivatives as anticonvulsant
RU2328502C2 (ru) Новые замещенные сульфаматные противосудорожные производные
TWI704137B (zh) 四取代烯化合物及其等之用途
TWI636981B (zh) 可作為鈉依賴性葡萄糖轉運子(sglt)抑制劑之化合物之製備方法
JP2020189862A (ja) ナトリウムチャネルの調節剤として有用なピリドンアミドのプロドラッグ
AU2002346042A1 (en) Novel anticonvulsant derivative salts
WO2018098472A1 (en) Crm1 inhibitors for treating epilepsy
DK149858B (da) Analogifremgangsmaade til fremstilling af morfinderivater
TW378207B (en) Benzylidene derivatives
RU2330041C2 (ru) Новые соли противосудорожных соединений
PL186411B1 (pl) Pochodne 3,4-dipodstawionego fenyloetanoloaminotetralinokarboksyamidu, kompozycja farmaceutyczna zawierająca te pochodne, zastosowanie tych pochodnych do wytwarzania kompozycji farmaceutycznej oraz zastosowanie tych pochodnych jako środka leczniczego
ES2259376T3 (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas y sus derivados, composiciones y procedimientos.
NO811212L (no) Fremgangsmaate ved fremstilling av antidepressive pyrrolypiperidiner.
UA112898C2 (uk) Індолкарбонітрили як селективні модулятори андрогенного рецептора
KR20050020799A (ko) 신규한 치환된 설파메이트 항경련 유도체